Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 146

1.

Neoadjuvant chemoradiotherapy followed by esophagectomy does not increase morbidity in patients over 70.

Blom RL, van Heijl M, Klinkenbijl JH, Bergman JJ, Wilmink JW, Richel DJ, Hulshof MC, Reitsma JB, Busch OR, van Berge Henegouwen MI.

Dis Esophagus. 2013 Jul;26(5):510-6. doi: 10.1111/j.1442-2050.2012.01394.x. Epub 2012 Aug 23.

PMID:
22925313
2.

Comparison of two neoadjuvant chemoradiotherapy regimens in patients with potentially curable esophageal carcinoma.

Blom RL, Sosef MN, Nap M, Lammering G, van den Berkmortel F, Hulshof MC, Meijer SL, Wilmink HW, van Berge Henegouwen MI.

Dis Esophagus. 2014 May-Jun;27(4):380-7. doi: 10.1111/dote.12110. Epub 2013 Sep 5.

PMID:
24006852
3.

Impact of neoadjuvant chemoradiotherapy on postoperative course after curative-intent transthoracic esophagectomy in esophageal cancer patients.

Bosch DJ, Muijs CT, Mul VE, Beukema JC, Hospers GA, Burgerhof JG, Plukker JT.

Ann Surg Oncol. 2014 Feb;21(2):605-11. doi: 10.1245/s10434-013-3316-8. Epub 2013 Oct 8.

PMID:
24100962
4.

Radiation dose does not influence anastomotic complications in patients with esophageal cancer treated with neoadjuvant chemoradiation and transhiatal esophagectomy.

Koëter M, van der Sangen MJ, Hurkmans CW, Luyer MD, Rutten HJ, Nieuwenhuijzen GA.

Radiat Oncol. 2015 Mar 6;10:59. doi: 10.1186/s13014-015-0361-4.

5.

Different recurrence pattern after neoadjuvant chemoradiotherapy compared to surgery alone in esophageal cancer patients.

Smit JK, Güler S, Beukema JC, Mul VE, Burgerhof JG, Hospers GA, Plukker JT.

Ann Surg Oncol. 2013 Nov;20(12):4008-15. doi: 10.1245/s10434-013-3102-7. Epub 2013 Jul 10.

PMID:
23838922
6.

Perioperative chemotherapy versus neoadjuvant chemoradiotherapy for esophageal or GEJ adenocarcinoma: A propensity score-matched analysis comparing toxicity, pathologic outcome, and survival.

Goense L, van der Sluis PC, van Rossum PSN, van der Horst S, Meijer GJ, Haj Mohammad N, van Vulpen M, Mook S, Ruurda JP, van Hillegersberg R.

J Surg Oncol. 2017 Jun;115(7):812-820. doi: 10.1002/jso.24596. Epub 2017 Mar 7.

PMID:
28267212
7.

CMISG1701: a multicenter prospective randomized phase III clinical trial comparing neoadjuvant chemoradiotherapy to neoadjuvant chemotherapy followed by minimally invasive esophagectomy in patients with locally advanced resectable esophageal squamous cell carcinoma (cT3-4aN0-1M0) (NCT03001596).

Tang H, Tan L, Shen Y, Wang H, Lin M, Feng M, Xu S, Guo W, Qian C, Liu T, Zeng Z, Hou Y, Yu Z, Jiang H, Li Z, Chen C, Lian C, Du M, Li H, Xie D, Yin J, Zhao N, Wang Q.

BMC Cancer. 2017 Jun 28;17(1):450. doi: 10.1186/s12885-017-3446-7.

8.

Totally minimally invasive esophagectomy after neoadjuvant chemoradiotherapy: Long-term oncologic outcomes.

Lubbers M, van Det MJ, Kreuger MJ, Hoekstra R, Hendriksen EM, Vermeer M, Kouwenhoven EA.

J Surg Oncol. 2018 Mar;117(4):651-658. doi: 10.1002/jso.24935.

PMID:
29603271
9.

Preoperative carboplatin and paclitaxel-based chemoradiotherapy for esophageal carcinoma: results of a modified CROSS regimen utilizing radiation doses greater than 41.4 Gy.

Nabavizadeh N, Shukla R, Elliott DA, Mitin T, Vaccaro GM, Dolan JP, Maggiore RJ, Schipper PH, Hunter JG, Thomas CR Jr, Holland JM.

Dis Esophagus. 2016 Aug;29(6):614-20. doi: 10.1111/dote.12377. Epub 2015 Jun 5.

PMID:
26043837
10.

Neoadjuvant chemoradiotherapy for esophageal carcinoma.

Zhang X, Watson DI, Jamieson GG, Bessell JR, Devitt PG.

Dis Esophagus. 2005;18(2):104-8.

PMID:
16053485
11.

High-Grade Toxicity to Neoadjuvant Treatment for Upper Gastrointestinal Carcinomas: What is the Impact on Perioperative and Oncologic Outcomes?

Robb WB, Messager M, Gronnier C, Tessier W, Hec F, Piessen G, Mariette C; FREGAT (French EsoGastric Tumor) working group - FRENCH (Fédération de Recherche en Chirurgie).

Ann Surg Oncol. 2015 Oct;22(11):3632-9. doi: 10.1245/s10434-015-4423-5. Epub 2015 Feb 13.

PMID:
25676845
12.

Outcomes of induction chemotherapy followed by chemoradiation using intensity-modulated radiation therapy for esophageal adenocarcinoma.

Gerber N, Ilson DH, Wu AJ, Janjigian YY, Kelsen DP, Zheng J, Zhang Z, Bains MS, Rizk N, Rusch VW, Goodman KA.

Dis Esophagus. 2014 Apr;27(3):235-41. doi: 10.1111/dote.12082. Epub 2013 Jun 24.

PMID:
23796070
13.

Effects of neoadjuvant therapy on perioperative morbidity in elderly patients undergoing esophagectomy for esophageal cancer.

Ruol A, Portale G, Castoro C, Merigliano S, Cagol M, Cavallin F, Chiarion Sileni V, Corti L, Rampado S, Costantini M, Ancona E.

Ann Surg Oncol. 2007 Nov;14(11):3243-50. Epub 2007 Aug 23.

PMID:
17713823
14.

Preoperative chemoradiation therapy decreases the number of lymph nodes resected during esophagectomy.

Issaka A, Ermerak NO, Bilgi Z, Kara VH, Celikel CA, Batirel HF.

World J Surg. 2015 Mar;39(3):721-6. doi: 10.1007/s00268-014-2847-x.

PMID:
25344144
15.

Multimodal treatment of locally advanced esophageal adenocarcinoma: which regimen should we choose? Outcome analysis of perioperative chemotherapy versus neoadjuvant chemoradiation in 105 patients.

Hoeppner J, Zirlik K, Brunner T, Bronsert P, Kulemann B, Sick O, Marjanovic G, Hopt UT, Makowiec F.

J Surg Oncol. 2014 Mar;109(3):287-93. doi: 10.1002/jso.23498. Epub 2013 Nov 26.

PMID:
24277235
16.

Comparison of survival among neoadjuvant chemoradiation responders, non-responders and patients receiving primary resection for locally advanced oesophageal squamous cell carcinoma: does neoadjuvant chemoradiation benefit all?

Hsu PK, Chien LI, Huang CS, Hsieh CC, Wu YC, Hsu WH, Chou TY.

Interact Cardiovasc Thorac Surg. 2013 Sep;17(3):460-6. doi: 10.1093/icvts/ivt216. Epub 2013 May 31.

17.

A Multi-institutional Analysis of Trimodality Therapy for Esophageal Cancer in Elderly Patients.

Lester SC, Lin SH, Chuong M, Bhooshan N, Liao Z, Arnett AL, James SE, Evans JD, Spears GM, Komaki R, Haddock MG, Mehta MP, Hallemeier CL, Merrell KW.

Int J Radiat Oncol Biol Phys. 2017 Jul 15;98(4):820-828. doi: 10.1016/j.ijrobp.2017.02.021. Epub 2017 Feb 20.

PMID:
28476435
18.

Adenocarcinoma of the esophagus and esophagogastric junction in patients older than 70 years: results of neoadjuvant radiochemotherapy followed by transthoracic esophagectomy.

Camerlo A, D'Journo XB, Ouattara M, Trousse D, Doddoli C, Thomas PA.

J Visc Surg. 2012 Jun;149(3):e203-10. doi: 10.1016/j.jviscsurg.2012.03.006. Epub 2012 May 23.

PMID:
22633088
19.

Neoadjuvant chemoradiation therapy in patients with surgically treated esophageal cancer.

Vermund H, Pories WJ, Hillard J, Wiley AL, Youngblood R.

Acta Oncol. 2001;40(5):558-65. Review.

PMID:
11669326
20.

Changes in body composition secondary to neoadjuvant chemotherapy for advanced esophageal cancer are related to the occurrence of postoperative complications after esophagectomy.

Ida S, Watanabe M, Karashima R, Imamura Y, Ishimoto T, Baba Y, Iwagami S, Sakamoto Y, Miyamoto Y, Yoshida N, Baba H.

Ann Surg Oncol. 2014 Oct;21(11):3675-9. doi: 10.1245/s10434-014-3737-z. Epub 2014 May 5.

PMID:
24793436

Supplemental Content

Support Center